本文へ移動
cccskills
無料GitHub で公開

esa-pa-treatment-unilateral

Determines whether to recommend unilateral laparoscopic adrenalectomy or medical therapy with a mineralocorticoid receptor antagonist for patients with confirmed unilateral PA (aldosterone-producing adenoma or unilateral adrenal hyperplasia). Triggered when discussing treatment options after confirming unilateral PA in a hypertensive patient with hypokalemia or resistant hypertension.

dromlakhani/MD2SKILL
インストール方法を見る

含まれるファイル（1）

  • SKILL.md2.8 KB

SKILL.md（原文）

インストールする前に、エージェントに与えられる指示の中身を確認できます。

Choose Between Surgery and Medical Treatment for Unilateral PA

STEP 1 — Gather Information

Confirm unilateral PA via adrenal venous sampling (AVS) or, in patients <35 years with spontaneous hypokalemia, marked aldosterone excess (PAC >20 ng/dL), and a unilateral adrenal lesion on CT consistent with adenoma. Assess surgical fitness (ASA class, comorbidities, coagulopathy) and patient treatment preference.
→ Proceed to assess surgical candidacy.

STEP 2 — Rule In / Rule Out

Is the patient able and willing to undergo laparoscopic adrenalectomy?

  • Yes → Proceed to STEP 3.
  • No → Recommend medical therapy with a mineralocorticoid receptor antagonist (MRA) and end.

STEP 3 — Classify or Stratify

For surgical candidates, determine if AVS can be omitted: age <35 years, spontaneous hypokalemia, marked aldosterone excess (PAC >20 ng/dL), and unilateral adrenal lesion on CT suggestive of adenoma.

  • All criteria met → Proceed to adrenalectomy without AVS.
  • Any criterion not met → Obtain AVS to confirm unilateral source.

STEP 4 — Decide

If AVS shows a lateralization ratio >4:1 (with cosyntropin) or criteria from STEP 3 were met, recommend unilateral laparoscopic adrenalectomy.
If AVS indicates bilateral disease, the patient declines surgery after counseling, or surgical contraindications exist, recommend medical therapy with an MRA (spironolactone preferred; eplerenone as alternative).

Clinical Guardrails / Mimics / Pitfalls

Do not proceed to surgery without confirming unilateral source unless strict age/hypokalemia/CT criteria are met. Avoid surgery in patients with uncontrolled coagulopathy, severe cardiopulmonary disease, or pregnancy. Do not mistake non‑functioning incidentaloma for APA; AVS is required when CT is equivocal. Monitor for hyperkalemia, gynecomastia, and menstrual disturbances with MRA; counsel patients on side‑effects before initiation.

Concrete Clinical Example

A 45‑year‑old woman with hypertension, spontaneous hypokalemia, ARR positive, AVS shows left‑right aldosterone/cortisol ratio 5:1, desires definitive treatment, has no surgical contraindications → undergoes laparoscopic left adrenalectomy.

Source: The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2016, doi:10.1210/jc.2015-4061

レビュー

まだレビューはありません。使ってみた感想をお寄せください。

ログインしてレビューを書く

同じリポジトリのスキル

概要と使いどころ

780g-pump-adjustment

無料

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-acth-stim-test-interpretation

無料

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-adrenal-crisis-treatment

無料

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-aed-ai-education

無料

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-aed-lt4-monitoring

無料

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-cortisol-cutoff-ai-diagnosis

無料

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

dromlakhani のスキルをすべて見る

このスキルの問題を報告する